Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
Open Access
- 14 October 2018
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2018, 1-8
- https://doi.org/10.1155/2018/1574806
Abstract
Background. Azithromycin exposure has been reported to increase the risk of QT prolongation and cardiovascular death. However, findings on the association between azithromycin and cardiovascular death are controversial, and azithromycin is still used in actual practice. Additionally, quantitative assessments of risk have not been performed, including the risk of QT prolongation when patients are exposed to azithromycin in a real-world clinical setting. Therefore, in this study, we aimed to evaluate the risk of exposure to azithromycin on QT prolongation in a real-world clinical setting using a 21-year medical history database of a tertiary medical institution. Methods. We analyzed the electrocardiogram results and relevant electronic health records of 402,607 subjects in a tertiary teaching hospital in Korea from 1996 to 2015. To evaluate the risk of QT prolongation of azithromycin, we conducted a case-control analysis using amoxicillin for comparison. Multiple logistic regression analysis was performed to correct for age, sex, accompanying drugs, and disease. Results. The odds ratio (OR) for QT prolongation (QTc>450 ms in male and >460 ms in female) on azithromycin exposure was 1.40 (95% confidence interval [CI], 1.23-1.59), and the OR for severe QT prolongation (QTc>500 ms) was 1.43 (95% CI, 1.13-1.82). On the other hand, the ORs on exposure to amoxicillin were 1.06 (95% CI, 0.97-1.15) and 0.88 (95% CI, 0.70-1.09). In a subgroup analysis, the risk of QT prolongation in patients aged between 60 and 80 years was significantly higher when they are exposed to azithromycin. Conclusions. The risk of QT prolongation was increased when patients, particularly the elderly aged 60-79 years, were exposed to azithromycin. Therefore, clinicians should pay exercise caution using azithromycin or consider using other antibiotics, such as amoxicillin, instead of azithromycin.Keywords
Funding Information
- Korea Health Industry Development Institute (HI16C0982, HI17C0970)
This publication has 27 references indexed in Scilit:
- Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and DeathAnnals of Family Medicine, 2014
- Azithromycin and the Risk of Cardiovascular ComplicationsJournal of Pharmacy Practice, 2013
- Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reportsTherapeutic Advances in Infectious Disease, 2013
- Cardiovascular Risks with Azithromycin and Other Antibacterial DrugsThe New England Journal of Medicine, 2013
- Use of Azithromycin and Death from Cardiovascular CausesThe New England Journal of Medicine, 2013
- Azithromycin and the Risk of Cardiovascular DeathThe New England Journal of Medicine, 2012
- Hypokalemia is associated with lengthening of QT interval in psychiatric patients on admissionPsychiatry Research, 2009
- AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part IV: The ST Segment, T and U Waves, and the QT Interval A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized ElectrocardiologyJournal of the American College of Cardiology, 2009
- Theoretical investigation of action potential duration dependence on extracellular Ca2+ in human cardiomyocytesJournal of Molecular and Cellular Cardiology, 2009
- Prolonged QTc Interval and Risk of Sudden Cardiac Death in a Population of Older AdultsJournal of the American College of Cardiology, 2006